Menu
Have questions about SeaStar Medical’s revolutionary Selective Cytopheretic Device (SCD)? Interested in SCD clinical trials? Want to become an investor or partner with a company that is passionate about advancing the critical-care paradigm and has the product to do it? Then just complete the form below, and we’ll be in touch!
SeaStar Medical is a privately held medical device company that has redefined how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs through novel solutions and services. SeaStar Medical’s focus is on removing pro-inflammatory mediators, known as cytokines, or transforming key immune system messengers from pro-inflammatory to reparative physiology. SeaStar Medical’s next generation technologies rely on science and innovation to build upon existing purification technologies to provide life-saving solutions to critically ill patients.
©SeaStar Medical 2021